Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Translational Research : the Journal of Laboratory and Clinical Medicine|June 13, 2022
Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressivenessGonçalo Outeiro-Pinho, Daniela Barros-Silva, Filipa Moreira-Silva, et al.
Bioorganic Chemistry|May 26, 2020
Unravelling the anticancer potential of functionalized chromeno[2,3-b]pyridines for breast cancer treatmentSofia Oliveira-Pinto, Olívia Pontes, Diogo Lopes, et al.
Cancers|March 6, 2021
Intracellular Autofluorescence as a New Biomarker for Cancer Stem Cells in GlioblastomaJoana Vieira de Castro, Céline S Gonçalves, Eduarda P Martins, et al.
Epigenetics|November 4, 2017
SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastizationMaria João Ferreira, Ana Sílvia Pires-Luís, Márcia Vieira-Coimbra, et al.
Journal of Translational Medicine|January 1, 2020
Overexpression of circulating MiR-30b-5p identifies advanced breast cancerHelena Estevão-Pereira, João Lobo, Sofia Salta, et al.
Neuroscience|May 25, 2021
Adenosine Inhibits Cell Proliferation Differently in Human Astrocytes and in Glioblastoma Cell LinesHelena Marcelino, Tiago M A Carvalho, Joana Tomás, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 22, 2022
Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progressionCláudia Martins-Lima, Vera Miranda-Gonçalves, João Lobo, et al.
Epigenetics|October 22, 2015
Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognosticationAna Sílvia Pires-Luís, Márcia Vieira-Coimbra, Filipa Quintela Vieira, et al.
Molecular Oncology|December 17, 2021
Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastomaEduarda P Martins, Céline S Gonçalves, Marta Pojo, et al.
Oncotarget|March 13, 2015
A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomideMarta Pojo, Céline S Gonçalves, Ana Xavier-Magalhães, et al.
Pageof 6